UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000022862 |
|---|---|
| Receipt number | R000026350 |
| Scientific Title | A prospective randomized controlled study on Suppression of Prostate Cancer by naftopidil (SNAP) |
| Date of disclosure of the study information | 2016/12/01 |
| Last modified on | 2023/06/30 08:31:08 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/06/23 22:30:23 | ||
| 2 | Update | 2016/06/24 12:59:07 | Public title |
|
| 3 | Update | 2016/07/01 20:20:46 | Public title Acronym |
|
| 4 | Update | 2016/07/01 20:24:26 | Name of primary person or sponsor Institute Organization Date of disclosure of the study information |
|
| 5 | Update | 2016/07/01 20:25:50 | Date of protocol fixation Anticipated trial start date |
|
| 6 | Update | 2016/07/01 20:29:48 | Date of disclosure of the study information |
|
| 7 | Update | 2016/09/18 20:03:51 | Public title |
|
| 8 | Update | 2016/09/18 20:08:23 | Narrative objectives1 Trial characteristics_1 Primary outcomes Key secondary outcomes |
|
| 9 | Update | 2016/09/18 20:14:20 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria Key exclusion criteria |
|
| 10 | Update | 2016/09/18 20:53:37 | Last name of lead principal investigator Organization Division name Address Last name of contact person Organization Division name Address Name of person sending information Organization Division name Address Institute Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 11 | Update | 2016/11/22 22:13:23 | Date of disclosure of the study information |
|
| 12 | Update | 2016/11/22 22:20:00 | Recruitment status Anticipated trial start date |
|
| 13 | Update | 2017/05/23 22:44:39 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Address Address TEL |
|
| 14 | Update | 2017/06/26 21:34:24 | Recruitment status |
|
| 15 | Update | 2018/04/18 20:59:26 | Public title Public title Acronym |
|
| 16 | Update | 2018/04/18 21:00:46 | Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
| 17 | Update | 2018/04/18 21:24:35 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 18 | Update | 2018/04/18 21:27:59 | Organization Organization Address Address TEL |
|
| 19 | Update | 2018/06/25 15:30:34 | Results |
|
| 20 | Update | 2020/12/31 15:30:22 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Institute Organization Organization Address Address Tel |
|
| 21 | Update | 2021/06/28 17:23:30 | Date of IRB Last follow-up date |
|
| 22 | Update | 2021/12/27 21:27:01 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
| 23 | Update | 2022/06/28 10:53:28 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
| 24 | Update | 2022/06/28 10:54:12 | Recruitment status |
|
| 25 | Update | 2022/06/28 11:03:41 | Number of participants that the trial has enrolled Results Results Results date posted |
|
| 26 | Update | 2022/06/28 11:11:43 | Organization Organization Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 27 | Update | 2023/06/30 08:31:08 | Other related information Other related information |
